The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Abstract
Resveratrol is a phytoalexin polyphenolic compound found in various plants, including grapes, berries, and peanuts. Multiple lines of compelling evidence indicate its beneficial effects on neurological, hepatic, and cardiovascular systems. Also one of the most striking biological activities of resveratrol soundly investigated during the late years has been its cancer-chemopreventive potential. In fact, recently it has been demonstrated that this stilbene blocks the multistep process of carcinogenesis at various stages: tumor initiation, promotion, and progression. One of the possible mechanisms for its biological activities involves downregulation of the inflammatory response through inhibition of synthesis and release of pro-inflammatory mediators, modification of eicosanoid synthesis, inhibition of activated immune cells, or inhibiting such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) via its inhibitory effects on nuclear factor (kappa)B (NF-(kappa)B) or the activator protein-1 (AP-1). More recent data provide interesting insights into the effect of this compound on the lifespan of yeast and flies, implicating the potential of resveratrol as an anti-aging agent in treating age-related human diseases. It is worthy to note that the phenolic compound possesses a low bioavailability and rapid clearance from the plasma. As the positive effects of resveratrol on inflammatory response regulation may comprise relevant clinical implications, the purpose of this article is to review its strong anti-inflammatory activity and the plausible mechanisms of these effects. Also, this review is intended to provide the reader an up-date of the bioavailability and pharmacokinetics of resveratrol and its impact on lifespan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–217 of 217
New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists
la Lastra, C., Sánchez‐Fidalgo, S., Villegas, I., & Motilva, V. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382909 · Cited by 59
Self-citationSuppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells
Shen, F., Chen, S., Dong, X., Zhong, H., Li, Y.-T., & Cheng, G.-F. (2003) · Journal of Asian Natural Products Research · doi:10.1080/1028602031000066852 · Cited by 58
Resveratrol inhibits TNF alpha-induced endothelial cell activation.
Bertelli, A. A. E., Baccalini, R., Battaglia, E., Falchi, M., & Ferrero, M. E. (2001) · PubMed · Cited by 58
Soleas, G. J., Goldberg, D. M., Karumanghiri, A., Diamandis, E. P., & Ng, E. (1995) · Journal of Wine Research · doi:10.1080/09571269508718028 · Cited by 54
The Human Inflammatory Response
Levy, J. H. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199600001-00008 · Cited by 52
Resveratrol modulates rat macrophage functions
Leiro, J. M., Álvarez, E., García, D., & Orallo, F. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00014-0 · Cited by 48
Kaneider, N. C., Egger, P., Dunzendorfer, S., Noris, P., Balduini, C. L., Gritti, D., Ricevuti, G., & Wiedermann, C. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000018305.95943.f7 · Cited by 46
Detection of dietary antioxidant phenolic compounds in human LDL.
Lamuela-Raventós, R. M., Covas, M., Fitó, M., Marrugat, J., & Boronat, M. D. C. D. L. T. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1870 · Cited by 44
Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
Sigusch, H. H., Henschel, L., Kraul, H., Merkel, U., & Hoffmann, A. (1994) · PubMed · Cited by 40
Drinking your health? It's too early to say
Corder, R., Crozier, A., & Kroon, P. A. (2003) · Nature · doi:10.1038/426119d · Cited by 36
Chang, T. K. H., Lee, W. B. K., & Ko, H. H. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y00-067 · Cited by 36
Szewczuk, L. M., & Penning, T. M. (2004) · Journal of Natural Products · doi:10.1021/np0498410 · Cited by 35
The Effects of Resveratrol on CYP1A1 Expression and Aryl Hydrocarbon Receptor Function In Vitro
Ciolino, H. P., & Yeh, G. C. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1283-7_14 · Cited by 30
In vivo inhibition of TNFα-induced vascular permeability by resveratrol
Fulgenzi, A., Bertelli, A. A. E., Magni, E., Ferrero, E., & Ferrero, M. E. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(01)02015-2 · Cited by 26
Tou, J., & Urbizo, C. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00137-1 · Cited by 26
Dubuisson, J. G., Dyess, D. L., & Gaubatz, J. W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00061-7 · Cited by 25
Cyclooxygenase inhibition in cancer prevention and treatment
Anderson, W. F., Umar, A., & Hawk, E. T. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.12.2193 · Cited by 21
Cited by
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
Quideau, S., Deffieux, D., Douat‐Casassus, C., & Pouységu, L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201000044 · Cited by 2,730
Antioxidant properties of resveratrol: A structure–activity insight
Gülçin, İ. (2010) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2009.07.002 · Cited by 894
Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects
Rahman, M. M., Rahaman, M. S., Islam, M. R., Rahman, F., Mithi, F. M., Alqahtani, T., Almikhlafi, M. A., Alghamdi, S. Q., Alruwaili, A. S., Hossain, M. S., et al. (2021) · Molecules · doi:10.3390/molecules27010233 · Cited by 852
Nutraceuticals: Facts and fiction
Espín, J. C., García-Conesa, M. T., & Tomás-Barberán, F. A. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.09.014 · Cited by 811
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
de la Lastra, C. A., & Villegas, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351156 · Cited by 740
Self-citation
Metadata
- Authors
- Alarcón de la Lastra, C., & Villegas, I.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 49
- Issue
- 5
- Pages
- 405-430
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2126619846
- Cited by
- 703
- References
- 217
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.